Good news for CGHS beneficiaries! Crackdown on overcharging, fraudulent billing by empanelled hospitals!

In a major relief for central government employees, the Ministry of Health and Family Welfare has issued new guidelines to curb fraudulent billing and overcharging by healthcare organisations (HCOs) empanelled under the Central Government Health Scheme (CGHS). The move to launch a crackdown against such hospitals to protect beneficiaries from malpractice and ensure compliance with CGHS protocols.

New CGHS guidelines to address complaints

The Directorate of CGHS has received complaints from beneficiaries regarding overcharging, denial of treatment, and fraudulent billing practices by empanelled hospitals. To tackle these issues, detailed guidelines have been introduced for strict adherence:

The new guidelines state that hospitals must not deny services to any eligible CGHS beneficiaries. “Beneficiaries/ In cases of patient death or when the patient is in a coma, the signatures of the beneficiaries’ attendants, along with their mobile numbers, must be obtained on the final bills for all Indoor and OPD services, including daycare, laboratory services, dialysis, etc.”

Also Read Govt has asked nationalised banks to prematurely retire underperforming employees? Here’s what FinMin says ‘Resentment among central govt employees’ for not setting up 8th Pay Commission: Lawmakers push FinMin for clarity on timeline 55th GST Council meeting : What to expect and why this meeting could be crucial? Explainer: What Banking Law Bill changes mean for banks & depositors

Also read: Govt to hike medical allowance of pensioners not availing CGHS facilities? Here’s what Centre has to say

Reporting requirements

HCOs must report specific cases, such as non-referral cases, emergency admissions, and direct visits of beneficiaries aged 70 and above, within 24 hours to the respective Additional Director via email; and failure to report cases will result in non-approval of claims, the ministry says.

Transparency in bed availability

Hospitals must prominently display the availability of beds in various wards and ICUs for the benefit of visiting patients; and beneficiaries must be allocated their entitled ward category. Assigning a lower category is prohibited, it says.

According to the latest guidelines, prescriptions must use generic names in capital letters. Specific brand insistence by HCOs is not allowed; and hospitals must accept medicines supplied by CGHS and ensure proper cold chain maintenance.

If hospitals refuse to accept CGHS-restricted medicines, they must provide the purchase invoice for reimbursement, the guidelines clarify.

For implants exceeding CGHS ceiling rates,

 » Read More

Related Articles

8th Pay Commission: Central govt to merge pay scales for Level 1-6 employees? Here’s what the new proposal says

8th Pay Commission: The National Council of Joint Consultative Machinery (JCM) Staff Side has submitted its recommendations for the Terms of Reference (ToR) for the 8th Central Pay Commission (CPC), advocating significant changes in pay structure, allowances and benefits for government employees. Among the key points of ToR is the proposal for merger of certain

Bharti Airtel Q3 Results: Profit surges 505.24% to Rs 14,781.20 crore, ARPU at Rs 245

Bharti Airtel on Thursday posted a profit of Rs 14,781.20 crore during the third quarter of FY25, reporting a growth of 505.24 per cent in comparison to Rs 2442.20 crore during the corresponding quarter of FY24. The telecom major recorded Q3 revenue from operations at Rs 45,129.30 crore, up 19.08 per cent as against Rs

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

8th Pay Commission: Central govt to merge pay scales for Level 1-6 employees? Here’s what the new proposal says

8th Pay Commission: The National Council of Joint Consultative Machinery (JCM) Staff Side has submitted its recommendations for the Terms of Reference (ToR) for the 8th Central Pay Commission (CPC), advocating significant changes in pay structure, allowances and benefits for government employees. Among the key points of ToR is the proposal for merger of certain

Bharti Airtel Q3 Results: Profit surges 505.24% to Rs 14,781.20 crore, ARPU at Rs 245

Bharti Airtel on Thursday posted a profit of Rs 14,781.20 crore during the third quarter of FY25, reporting a growth of 505.24 per cent in comparison to Rs 2442.20 crore during the corresponding quarter of FY24. The telecom major recorded Q3 revenue from operations at Rs 45,129.30 crore, up 19.08 per cent as against Rs

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

Two banking stocks to watch ahead of the RBI Policy

By Kiran Jani Bank Nifty reached its all-time high of 54,467 in September 2024. Following this peak, the index experienced a correction, dipping to 47,844 in January 2025—a decline of 7.29%. Despite this pullback, Kotak Bank and ICICI Bank showed relative resilience, delivering returns of 1.61% and -4.20%, respectively, during the same period. Source: Investing.com

New Tax Regime: These deductions, exemptions still available for you

The Indian government introduced a new tax regime in 2020, offering lower tax rates while removing several exemptions and deductions available under the old system. Initially optional, this regime became the default in 2023, requiring taxpayers to opt out if they wished to continue under the old structure. Despite the removal of many benefits, certain